This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval to label the eversense sensor as magnetic resonance (mr) conditional.
| Device | Eversense Continuous Glucose Monitoring System |
| Classification Name | Continuous Glucose Monitor, Implanted, Adjunctive Use |
| Generic Name | Continuous Glucose Monitor, Implanted, Adjunctive Use |
| Applicant | SENSEONICS, INCORPORATED |
| Date Received | 2018-12-11 |
| Decision Date | 2019-01-28 |
| PMA | P160048 |
| Supplement | S008 |
| Product Code | QCD |
| Advisory Committee | Clinical Chemistry |
| Supplement Type | Real-time Process |
| Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | SENSEONICS, INCORPORATED 20451 Seneca Meadows Parkway germantown, MD 20876-7005 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P160048 | Original Filing | |
| S017 | 2020-11-12 | 30-day Notice |
| S016 | ||
| S015 | ||
| S014 | 2019-08-27 | Normal 180 Day Track No User Fee |
| S013 | 2019-07-31 | 30-day Notice |
| S012 | ||
| S011 | 2019-06-27 | Normal 180 Day Track |
| S010 | 2019-06-24 | 30-day Notice |
| S009 | 2019-05-28 | 30-day Notice |
| S008 | 2018-12-11 | Real-time Process |
| S007 | 2018-11-28 | Normal 180 Day Track No User Fee |
| S006 | ||
| S005 | 2018-09-11 | Real-time Process |
| S004 | 2018-09-07 | Real-time Process |
| S003 | 2018-08-27 | Normal 180 Day Track No User Fee |
| S002 | 2018-08-07 | Normal 180 Day Track |
| S001 | 2018-07-20 | Normal 180 Day Track No User Fee |